The FDA has approved Roche’s MRSA test, a technology that could give healthcare providers the ability to detect infections faster than traditional culture-based tests.
Roche Diabetes Care’s Michael Goetzl explains how the company is spearheading a combined digital-pharmaceutical approach to diabetes and how pharma firms can best embrace holistic strategie
Roche and Novartis are among the pharmaceuticals companies who have agreed to cut prices of some of their newest drugs by 61% on average to get them reimbursed in China, according to a repo